Clinical Trials Browser

Phase 1 × Neuroendocrine Tumors × Sorafenib × Clear all

NCT00942682 2014-04-29

Sorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors

Phase 1 Completed

Carcinoid Tumor, Adenoma, Islet Cell, Neuroendocrine Tumors